Company profile

Tianda Pharmaceuticals Limited (“Tianda Pharmaceuticals”, listed on the Hong Kong Stock Exchange, stock code: 0455) implements the three strategic policy objectives: development of Traditional Chinese medicine (“TCM”) as its foundation, development of innovative drugs and medical technologies, as well as development of high-quality medical and healthcare services. It is committed to becoming a competitive pharmaceutical enterprise and core value chain in pharmaceuticals, medical technology, TCM treatment and health management.

 

 

 

 

 

More

Financial Reports

ANNUAL REPORT 2020
Interim Report 2019

News Centre